SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 14D9/A - Solicitation, recommendation statements: [Amend]
SEC Accession No. 0001193125-21-118574
Filing Date
2021-04-16
Accepted
2021-04-16 08:42:51
Documents
1

Document Format Files

Seq Description Document Type Size
1 SC 14D9/A d173894dsc14d9a.htm SC 14D9/A 17679
  Complete submission text file 0001193125-21-118574.txt   19473
Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Filed by) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A
SIC: 2834 Pharmaceutical Preparations

Mailing Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 111 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 415-365-5600
FIVE PRIME THERAPEUTICS, INC. (Subject) CIK: 0001175505 (see all company filings)

IRS No.: 260038620 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 14D9/A | Act: 34 | File No.: 005-87623 | Film No.: 21830193
SIC: 2834 Pharmaceutical Preparations